Computational oral absorption simulation of free base drugs

International Journal of Pharmaceutics
Kiyohiko Sugano

Abstract

The purpose of the present study was to investigate the oral absorption simulation of free base drugs. In the case of a low solubility free base drug, a portion of drug particles remains incompletely dissolved during the stomach transit and can reach the small intestine. As the pH is neutralized in the small intestine, the solubility of the drug decreases and the concentration gradient around the particles becomes a negative value. The drug particles would then grow because of this negative concentration gradient resulting in a reduction of the dissolved drug concentration. The modified Nernst Brunner equation was used to simulate both particle dissolution and growth (particle growth is the opposite phenomena of particle dissolution). Albendazole, aprepitant, dipyridamole, gefitinib and ketoconazole were used as model drugs (all free solid form (not salts)). The effect of stomach pH on oral absorption was appropriately simulated. Based on the simulation results, it was suggested that the dissolution patterns in the gastrointestinal tract were significantly different depending on the dose-solubility ratio in the stomach.

References

Jan 1, 1983·Thrombosis Research. Supplement·T D Bjornsson, C Mahony
Jan 1, 1981·Journal of Pharmaceutical Sciences·K G MooneyV J Stella
Aug 1, 1994·Clinical Radiology·S C WardJ Sutton
Apr 1, 1993·Antimicrobial Agents and Chemotherapy·J A BaroneV Van de Velde
May 20, 1998·Journal of Pharmaceutical Sciences·R E OliverM Rowland
Sep 22, 1998·Pharmaceutical Development and Technology·D DíazC M Escobar Llanos
Apr 27, 1999·The Journal of Pharmacy and Pharmacology·N KohriK Miyazaki
Sep 16, 1999·International Journal of Pharmaceutics·L X Yu, G L Amidon
Mar 21, 2001·Biological & Pharmaceutical Bulletin·M MoriharaH Ogata
Mar 4, 2003·Nature Reviews. Drug Discovery·Han van de Waterbeemd, Eric Gifford
Apr 25, 2003·International Journal of Pharmaceutics·Kiyohiko SuganoYoshinori Aso
Mar 1, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Alex AvdeefStaffan Tavelin
Nov 25, 2005·Journal of Pharmaceutical Sciences·L KalantziDirk M Barends
Jan 18, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jun-ichi JinnoToshikiro Kimura
Dec 26, 2006·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·H KortejärviM Yliperttula
Mar 21, 2007·Pharmaceutical Research·Maria VertzoniChristos Reppas
May 8, 2007·International Journal of Pharmaceutics·Ebba BergmanHans Lennernäs
Jun 19, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Markus VogtJennifer B Dressman
Jul 10, 2007·Advanced Drug Delivery Reviews·Abu T M Serajuddin
Sep 11, 2007·Drug Metabolism and Pharmacokinetics·Kiyohiko SuganoTakashi Mano
Sep 11, 2007·Journal of Pharmaceutical Sciences·Arimichi OkazakiKiyohiko Sugano
Feb 5, 2008·International Journal of Pharmaceutics·Xiaoping CaoBruno C Hancock
Nov 11, 2008·International Journal of Pharmaceutics·Kiyohiko Sugano
Mar 10, 2009·Pharmaceutical Research·Sarah ClaryssePatrick Augustijns
Apr 1, 2009·Expert Opinion on Drug Metabolism & Toxicology·Kiyohiko Sugano
May 5, 2009·The AAPS Journal·Steven C Sutton
Jun 6, 2009·International Journal of Pharmaceutics·C G WilsonH C Swaisland
Jun 9, 2009·International Journal of Pharmaceutics·Kiyohiko Sugano
Nov 26, 2009·Chemistry & Biodiversity·Alex AvdeefDmytro Voloboy
Nov 26, 2009·Chemistry & Biodiversity·Kiyohiko Sugano
Mar 24, 2010·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Kiyohiko SuganoShinji Yamashita

❮ Previous
Next ❯

Citations

Dec 19, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Sara CarlertBertil Abrahamsson
Jan 15, 2014·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Kerstin J FrankKarl G Wagner
Jan 15, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Zehedina KhatunYong-kyu Lee
Feb 14, 2016·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Makoto KataokaShinji Yamashita
Feb 26, 2015·Journal of Pharmaceutical Sciences·Kiyohiko Sugano, Katsuhide Terada
Feb 18, 2016·Journal of Pharmaceutical Sciences·Masashi MizoguchiTakashi Inui
Dec 25, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Atsushi Kambayashi, Jennifer B Dressman
Nov 26, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Alexandros KourentasMira Symillides
Sep 1, 2015·Therapeutic Delivery·Jonas H Fagerberg, Christel As Bergström
Jun 25, 2016·Molecular Pharmaceutics·Hiroshi KoyamaKiyohiko Sugano
Mar 16, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David Planchard
Mar 7, 2017·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Yasuhiro TsumeGordon L Amidon
Oct 1, 2010·Therapeutic Delivery·Mark Habgood, Joakim Ek
Sep 10, 2020·Pharmaceutics·Naoya MatsumuraKiyohiko Sugano
May 11, 2021·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Jibin LiIsmael J Hidalgo
Sep 8, 2012·Molecular Pharmaceutics·Sara CarlertBertil Abrahamsson
Oct 2, 2021·AAPS PharmSciTech·Gayathri Ramachandran, M S Sudheesh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
Yasushi ShonoJennifer B Dressman
The Journal of Pharmacy and Pharmacology
Edmund S KostewiczJennifer B Dressman
© 2021 Meta ULC. All rights reserved